Abstract
Increasingly, patients are receiving treatment at facilities other than hospitals, including long-term-health care facilities, assisted-living environments, rehabilitation facilities, and dialysis centers. As with hospital environments, nonhospital settings present their own unique risks of pneumonia. Traditionally, pneumonia in these facilities has been categorized as community-acquired pneumonia (CAP). However, the new designation for pneumonias acquired in these settings is health care-associated pneumonia (HCAP), which covers pneumonias acquired in health care environments outside of the traditional hospital setting and excludes hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and CAP. Although HCAP is currently treated with the same protocols as CAP, recent evidence indicates that HCAP differs from CAP with respect to pathogens and prognosis and, in fact, more closely resembles HAP and VAP. The HCAP Summit convened national infectious disease opinion leaders for the purpose of analyzing current literature, clinical trial data, diagnostic considerations, therapeutic options, and treatment guidelines related to HCAP. After an in-depth analysis of these areas, the infectious disease investigators participating in the summit were surveyed with regard to 10 clinical practice statements. The results were then compared with results of the same survey as completed by 744 Infectious Diseases Society of America members. The similarities and differences between those survey results are the basis of this publication.
| Original language | English |
|---|---|
| Journal | Clinical Infectious Diseases |
| Volume | 46 |
| Issue number | SUPPL. 4 |
| DOIs | |
| State | Published - Apr 15 2008 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Immunology
Cite this
Health care-associated pneumonia (HCAP) : A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit. / Kollef, Marin H.; Morrow, Lee E.; Baughman, Robert P.; Craven, Donald E.; McGowan, John E.; Micek, Scott T.; Niederman, Michael S.; Ost, David; Paterson, David L.; Segreti, John.
In: Clinical Infectious Diseases, Vol. 46, No. SUPPL. 4, 15.04.2008.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Health care-associated pneumonia (HCAP)
T2 - A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit
AU - Kollef, Marin H.
AU - Morrow, Lee E.
AU - Baughman, Robert P.
AU - Craven, Donald E.
AU - McGowan, John E.
AU - Micek, Scott T.
AU - Niederman, Michael S.
AU - Ost, David
AU - Paterson, David L.
AU - Segreti, John
PY - 2008/4/15
Y1 - 2008/4/15
N2 - Increasingly, patients are receiving treatment at facilities other than hospitals, including long-term-health care facilities, assisted-living environments, rehabilitation facilities, and dialysis centers. As with hospital environments, nonhospital settings present their own unique risks of pneumonia. Traditionally, pneumonia in these facilities has been categorized as community-acquired pneumonia (CAP). However, the new designation for pneumonias acquired in these settings is health care-associated pneumonia (HCAP), which covers pneumonias acquired in health care environments outside of the traditional hospital setting and excludes hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and CAP. Although HCAP is currently treated with the same protocols as CAP, recent evidence indicates that HCAP differs from CAP with respect to pathogens and prognosis and, in fact, more closely resembles HAP and VAP. The HCAP Summit convened national infectious disease opinion leaders for the purpose of analyzing current literature, clinical trial data, diagnostic considerations, therapeutic options, and treatment guidelines related to HCAP. After an in-depth analysis of these areas, the infectious disease investigators participating in the summit were surveyed with regard to 10 clinical practice statements. The results were then compared with results of the same survey as completed by 744 Infectious Diseases Society of America members. The similarities and differences between those survey results are the basis of this publication.
AB - Increasingly, patients are receiving treatment at facilities other than hospitals, including long-term-health care facilities, assisted-living environments, rehabilitation facilities, and dialysis centers. As with hospital environments, nonhospital settings present their own unique risks of pneumonia. Traditionally, pneumonia in these facilities has been categorized as community-acquired pneumonia (CAP). However, the new designation for pneumonias acquired in these settings is health care-associated pneumonia (HCAP), which covers pneumonias acquired in health care environments outside of the traditional hospital setting and excludes hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and CAP. Although HCAP is currently treated with the same protocols as CAP, recent evidence indicates that HCAP differs from CAP with respect to pathogens and prognosis and, in fact, more closely resembles HAP and VAP. The HCAP Summit convened national infectious disease opinion leaders for the purpose of analyzing current literature, clinical trial data, diagnostic considerations, therapeutic options, and treatment guidelines related to HCAP. After an in-depth analysis of these areas, the infectious disease investigators participating in the summit were surveyed with regard to 10 clinical practice statements. The results were then compared with results of the same survey as completed by 744 Infectious Diseases Society of America members. The similarities and differences between those survey results are the basis of this publication.
UR - http://www.scopus.com/inward/record.url?scp=42549136960&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42549136960&partnerID=8YFLogxK
U2 - 10.1086/526355
DO - 10.1086/526355
M3 - Article
C2 - 18429676
AN - SCOPUS:42549136960
VL - 46
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - SUPPL. 4
ER -